CBD Life Sciences Inc (PK) (CBDL) Cotización

LOL. The truth hurts huh?

Packers suck stfu now

$CBDL Announces Its Official Launch on Groupon.com

https://www.newswire.com/news/cbd-life-sciences-inc-cbdl-announces-its-official-launch-on-groupon-com-22514363

You really are clueless. It had the one run after the r/s. Like like before after others. Then trades like to is as dilution never ends. When it ends up diluted down to .00001 again. Maybe you will stop ignoring the dilution scam this is. The only shares being sold are by the company. Every day all day. You will end up same as others before this r/s. Losing. The company depends on fools to keep buying. After 4 years sales are tiny and they get rich selling shares not product.

CBD Life Sciences Inc. $CBDL
@CBDL_StockOTC
·
2m
Good afternoon $CBDL, we’re excited to announce that we believe we will have a deal for the Armed Forces by next week.

We’re taking our products to biker week in Cave Creek and expect to get some strong revenue from sales there as well 90k+ people.

We’re now live on Groupon
Show more

Many good news are not priced in, this is a undervalued stock, will take off soon, once dilution stopped, it will fly. Time to buy and hold on. I believe that it will break out 0.01 this year any time soon..

Good Morning $CBDL

IMO smart money is placing a bet on the company's success.
"An open market share buyback program has also been initiated, signaling a robust vote of confidence in CBDL's growth strategy and financial stability. This strategic decision to repurchase outstanding shares over time underscores the company's dedication to bolstering shareholder equity, while simultaneously streamlining the share pool to improve earnings per share and overall market appeal."

[What Does This Mean for Shareholders?
The reduction of 3.5 billion authorized shares is an unprecedented move that marks a turning point for CBDL and its stakeholders. By significantly decreasing the authorized share count, CBDL enhances its financial health, reduces dilution risks, and sets the stage for a more attractive investment profile.]

thanks for your concern. could be we are in for another hard run up. risk v reward is attractive.

For years now people like you have said how this is a good buy. So far wrong. The only shares filling buys are dilution. Go throw your money away. Many have before. They need fools to keep buying shares. They have taken from a lot of them.

No thanks better cover up.

Wrong. It is a dilution scam. Only ones selling shares is the company. Ignore the history here and lose it all. Keep buying. Like before last r/s will lose it all.

Risk v. Reward this is a screaming buy. So I did. Good luck to all longs.
I want to thank the shorts and fake naysayers.

At these levels and with sales tiny. Even if increased which I doubt. It is still tiny under 1 million. The only one selling shares is the company. That is how they keep going and made millions. By selling billions of shares to suckers. Then doing r/s and do it all over again. They made millions selling shares not product. This will end up again at .0001 and done. Until the next r/s. Same as before.

news - .0004 & STILL stagnating . . . blah

By tapping into Groupon's powerhouse of 22.5 million active deal-seekers, CBDL gains access to a high-intent consumer base actively looking for health, wellness, and lifestyle products. With Groupon generating over $550 million in annual revenue and averaging more than 40 million transactions per year, this move significantly amplifies CBDL's direct-to-consumer reach and revenue potential.

"This is a major leap forward for CBD Life Sciences Inc.," said Lisa Nelson, President & CEO of CBDL. "We are laser-focused on expansion, and being featured on Groupon is a testament to our commitment to making high-quality CBD products more accessible than ever. With Groupon's massive audience and purchasing power, we are unlocking new revenue streams, increasing our market penetration, and taking our e-commerce strategy to the next level."

CBD Life Sciences Inc. (CBDL) Announces Its Official Launch on Groupon.comPress Release | 02/04/2025

Groupon, with over 22.5 million active users and generating more than $550 million in annual revenue, now features CBDL's top-tier wellness products, unlocking massive e-commerce potential and positioning the company for explosive growth in the booming CBD industry.

SCOTTSDALE, AZ / ACCESS Newswire / February 4, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD and wellness market, is thrilled to announce its official launch on Groupon.com, one of the world's largest e-commerce deal platforms. This strategic expansion marks a major milestone in CBDL's aggressive growth strategy, placing its premium CBD products in front of millions of new potential customers while solidifying its position in the rapidly expanding $47 billion CBD industry.

By tapping into Groupon's powerhouse of 22.5 million active deal-seekers, CBDL gains access to a high-intent consumer base actively looking for health, wellness, and lifestyle products. With Groupon generating over $550 million in annual revenue and averaging more than 40 million transactions per year, this move significantly amplifies CBDL's direct-to-consumer reach and revenue potential.

A Power Move for Growth & Market Expansion

CBDL's official debut on Groupon is a game-changer. By leveraging Groupon's built-in marketing, deal-driven shopping experience, and trusted customer base, CBDL expects to see rapid traction, increased brand awareness, and accelerated sales growth.

"This is a major leap forward for CBD Life Sciences Inc.," said Lisa Nelson, President & CEO of CBDL. "We are laser-focused on expansion, and being featured on Groupon is a testament to our commitment to making high-quality CBD products more accessible than ever. With Groupon's massive audience and purchasing power, we are unlocking new revenue streams, increasing our market penetration, and taking our e-commerce strategy to the next level."

CBDL's first offering on Groupon, listed as The CBD Vault, features a selection of the company's best-selling CBD products designed for pain relief, relaxation, and overall wellness. This initial launch is just the beginning, as CBDL plans to continuously expand its product lineup to meet growing demand and solidify its presence in the digital retail space.

Why This Matters for Investors

This latest expansion aligns perfectly with CBDL's long-term growth strategy and positions the company to capitalize on the surging demand for premium CBD products in the U.S. and beyond.

E-commerce Dominance: Groupon's extensive reach provides CBDL with a direct gateway to millions of engaged shoppers, increasing brand exposure and revenue potential.

Scalability & Revenue Acceleration: With Groupon's marketing engine driving traffic, CBDL anticipates a strong increase in direct-to-consumer sales, boosting top-line revenue.

Industry Growth: The global CBD market is projected to exceed $47 billion by 2028, with the U.S. CBD market alone expected to reach $16 billion by 2026-CBDL is strategically positioning itself to capture significant market share.

Increased Shareholder Value: Every expansion move contributes to CBDL's aggressive trajectory toward sustained profitability, driving long-term shareholder value and bolstering investor confidence.

As CBDL continues its upward momentum with strategic partnerships, new product launches, and expansion into high-traffic retail platforms, this is just the beginning of what promises to be a breakthrough year for the company.

ð??? Shop CBDL on Groupon Now: The CBD Vault on Groupon

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. (OTC: CBDL) is a leading innovator in the CBD and wellness sector, committed to delivering premium, science-backed CBD products designed to enhance health, performance, and overall well-being. With an ever-expanding product portfolio and aggressive market expansion strategy, CBDL is shaping the future of CBD retail, both online and in major marketplaces nationwide.

For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences, Inc.

Related Images

https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Announces-Its-Official-Launch-on-Grouponcom?id=466598
View the original press release on ACCESS Newswire


CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash PlatformPress Release | 01/14/2025

With DoorDash projecting over $10 billion in 2025 revenue, CBD Life Sciences Inc. is set to tap into one of the fastest-growing delivery markets in the country, potentially unlocking a multi-million dollar revenue stream and driving a projected 30-40% increase in annual revenue for CBDL.

SCOTTSDALE, ARIZONA / ACCESSWIRE / January 14, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leading innovator in the CBD industry, proudly announces that it is in the final stages of securing approval to sell its premium CBD products on DoorDash, one of the most prominent on-demand delivery platforms in the United States. This development represents a significant step forward in CBDL's ongoing strategy to broaden its market reach and deliver high-quality CBD offerings to customers with greater convenience.

DoorDash's projected multi-billion-dollar revenue for 2025 underscores the massive growth potential in on-demand services. With a footprint spanning millions of households across the nation, DoorDash provides a unique and scalable avenue for CBDL to reach an even broader audience, enhancing product accessibility and driving exponential revenue growth. The CBD industry continues to surge, and this opportunity positions CBDL as a key player in transforming how consumers access wellness products.

"Being able to sell on DoorDash opens up an entirely new market for us," said Lisa Nelson, President and CEO of CBD Life Sciences Inc. "We are excited about the prospect of making our premium CBD products available through one of the most trusted delivery platforms in the U.S. This move not only aligns with our commitment to innovation but also positions us for substantial revenue growth in 2025 and beyond."

Once approved, CBDL plans to offer a wide range of its bestselling products, including high-potency 3000MG Pain Relief Cream and CBD Gummies, with same-day delivery in select markets. The company's CBD Gummies, known for their consistency and great taste, have been a hit with customers seeking convenient, delicious ways to incorporate wellness into their daily lives. This initiative enhances CBDL's competitive edge by catering to consumer demand for fast, convenient access to wellness products.

Expanding Market Potential and Growing Investor Confidence

In addition to expanding distribution channels, this opportunity also reinforces CBDL's aggressive growth strategy aimed at increasing shareholder value. Recent industry reports indicate that the U.S. CBD market is poised to grow at a compound annual growth rate (CAGR) of 28% over the next five years, driven by increased consumer awareness and demand for natural wellness solutions. With DoorDash's extensive logistics network and CBDL's premium product line, this expansion is expected to drive significant market penetration.

CBDL's focus on innovation doesn't stop at delivery partnerships. The company is also ramping up research and development efforts to introduce new products that cater to evolving consumer needs. These efforts reflect CBDL's dedication to staying ahead of market trends and ensuring sustained growth.

"This DoorDash opportunity is a game-changer," Nelson added. "It positions us at the forefront of a rapidly evolving market and gives us a significant advantage in capturing more market share while providing a seamless buying experience for our customers. We anticipate strong revenue growth and improved brand recognition as a direct result of this initiative."

CBDL continues to explore additional partnerships and opportunities to expand its reach in both the U.S. and international markets. With a strong product portfolio, a robust distribution strategy, and a relentless focus on growth, the company remains dedicated to delivering long-term value to its investors. Additionally, the company is committed to ongoing product innovation to meet the evolving needs of health-conscious consumers.

About CBD Life Sciences Inc.

CBD Life Sciences Inc. (OTC: CBDL) is a vertically integrated company focused on the development and commercialization of high-quality, innovative CBD-based products. With a diverse product line ranging from pain relief creams to gummies, CBDL is committed to enhancing the well-being of its customers through science-backed solutions. The company's mission is to lead the CBD industry by delivering exceptional products that promote better living.

For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com

Doordash Website: https://www.doordash.com/

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.


View the original press release on accesswire.com
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-in-Final-Stages-to-Sell-CBD-Products-on-DoorDash-Platform?id=464444


CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthPress Release | 01/07/2025

Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line.

SCOTTSDALE, AZ / ACCESSWIRE / January 7, 2025 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in wellness innovation, is thrilled to announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market.

Expanding Market Potential

The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions.

Lisa Nelson, President and CEO of CBDL, commented on this milestone:
"This approval is more than just an entry into Walmart-it's a strategic step toward scaling our operations and driving significant shareholder value. We're not only gaining access to millions of health-conscious consumers but also leveraging Walmart's trusted platform to amplify our brand's reach and credibility."

The Walmart Marketplace Advantage

Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base.

Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network.

Revenue Impact and Growth Strategy

CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements.

The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry.

As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.

Commitment to Shareholders

CBDL remains steadfast in its mission to drive long-term shareholder value by continuously expanding into high-growth markets. The Walmart Marketplace approval is expected to further strengthen investor confidence, positioning the company as a market leader in innovative health solutions. With an expanding portfolio of products and a growing number of retail partnerships, CBDL is on track to deliver sustained financial growth and operational excellence.

Customers can purchase the product directly by visiting this link: https://www.walmart.com/ip/Rise-Mushrooms-Lion-s-Mane-Blend/14843512001?classType=REGULAR&from=/search

About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC:CBDL) is a pioneering health and wellness company specializing in high-quality CBD products and functional supplements. With a focus on innovation, the company leverages advanced technology and scientific research to develop effective solutions that promote overall well-being. CBDL's diverse product range includes nano-enhanced CBD creamers, pain relief creams, and functional mushroom blends.

For more information about CBD Life Sciences, Inc. and its product offerings, visit www.thecbdvault.com

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.

Related Images


View the original press release on accesswire.com
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Secures-Breakthrough-Walmart-Marketplace-Approval-for-Mushroom-Supplement-Setting-the-Stage-f?id=463827

This will be a huge revenue driver and will expand our online sales drastically!

Our products are live here -> https://groupon.com/deals/the-cbd-vault

Good morning $CBDL shareholders! We’re very excited to announce that we have our official launch on http://Groupon.com

This will be a huge revenue driver and will expand our online sales drastically!

Our products are live here -> https://groupon.com/deals/the-cbd-vault

$CBDL on #Groupon ---> https://www.groupon.com/deals/the-cbd-vault

https://www.newswire.com/news/cbd-life-sciences-inc-cbdl-announces-its-official-launch-on-groupon-com-22514363

$CBDL Announces Its Official Launch on Groupon.com

https://www.newswire.com/news/cbd-life-sciences-inc-cbdl-announces-its-official-launch-on-groupon-com-22514363

We’re excited to announce that our online sales are up over 80%!

We have a meeting with the armed forces next week for our mushroom products so expect updates very soon.

$CBDL

A Share buyback? Lies. They are filling buys every day with new shares issued. No shareholder at these levels has a gain to sell. Up 80% over 167,000 in revenues. Sure. LOL.

Our meeting with the Air Force for our mushroom products is this week!

New products are driving our online sale up over 80%.

Reduced the authorized and initiated a share buyback.

Expect more updates VIA Press Release very soon!
$CBDL

Good Morning $CBDL

Good afternoon $CBDL shareholders! We’re excited to announce that our online sales are up over 80%!

We have a meeting with the armed forces next week for our mushroom products so expect updates very soon.

$CBDL

After 4 years and billions and billions in dilution. Last fling showed 167,000 in revenues. They have no money. They make money selling shares. Also at these levels. No shares holders have a gain. That has never changed. At these price levels. After another r/s. NO shareholders are selling unless for a loss. Only the company is selling shares.

CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback

Good Morning $CBDL

Stupid CEO if you want to sell shares, why not let PPS up then you can sell shares at higher PPS to get more cash??

Yes, Dilution: O/S shares increasing. Company has no money to buy back shares, PR didn't say how many shares they will buy back? It's lie. They want to sell shares to get cash to buy a Pharmacy in New Yorke

O/S 12/03/24 2,782,027,499 shares
O/S 01/29/25 3,097,305,276 shares

More lies. So the company are the ones selling new shares to fill buys. Yet they say share buyback the opposite of what they are doing. Dilution never ends here.

Never ending dilution. The history of this is all there to see. Like shareholders before this r/s. To ignore it and buy. You will lose it all. Only ones selling shares this low. The company.

Good morning $CBDL shareholders! The company is talking to a couple of pro golfers to become ambassadors to the CBD line.

In talks with the Air Force regarding the mushroom supplement product.

More acquisitions very soon stay tuned!

An open market share buyback program has also been initiated, signaling a robust vote of confidence in CBDL's growth strategy and financial stability. This strategic decision to repurchase outstanding shares over time underscores the company's dedication to bolstering shareholder equity, while simultaneously streamlining the share pool to improve earnings per share and overall market appeal.

CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback

Good Morning $CBDL

Big dilution day today. Another 78 million.

The revenue even if what they say is true is still tiny. Share buy back. Wrong as each day buys filled by dilution. As volume dries up price will go down. Just like it has before this r/s. Amazing they still get so many suckers to by.

Good morning $CBDL shareholders. Company is looking into AI integration for faster and more seamless transactions. We’re looking for more dispensary’s to acquire in the 8 figure + revenue side! Big updates very soon

Share buyback authorized reduction are all very positive excited to see what's next 

Good Morning $CBDL

What are you guys waiting on? New here.

Sales are tiny. This scam just lies. How is there a share buyback? When the company are only ones selling shares at these levels? They do not have any money without selling shares.

We’re happy to announce our share buyback in addition to the 3.5 billion authorized reduction. We’ve also filed a FORM 1-U stating that we’ve initiated the open market share buyback! Huge steps for our shareholder value going forward."

"Good morning $CBDL shareholders! We’re happy to announce our share buyback in addition to the 3.5 billion authorized reduction. We’ve also filed a FORM 1-U stating that we’ve initiated the open market share buyback! Huge steps for our shareholder value going forward."

Good Morning $CBDL

This very undervalued stock will take off soon any day. Just buy and wait to make fast money

There are so many paces on line and retail selling CBD products. This is another thing that will not do much. They must really be desperate to sell more shares. Like they always are.